Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose vs Voglibose in T2DM Inadequately Controlled with Insulin Glargine
NCT00970528Phase 4Completed
- Sponsor
- Bayer
- Start
- Nov 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acarbose in type 2 diabetes mellitus (T2DM), sponsored by Bayer. Started Nov 2009; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00970528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970528.